GGrantIndex
← Leaderboards

Maxim Frolov

University Of Illinois At Chicago

$8,882,118
Attributed
$8,882,118
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $681.6K · FY200725
$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,882,118 · 4

By mechanism

R01$4,759,651 · 3
R35$4,122,467 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Illinois At Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Pathway Interactions

Research focus

Pathway InteractionsCell ProliferationDrosophila GenusFamilyMalignant NeoplasmsRetinoblastomaCellsTumor Suppressor ProteinsIn VivoRetinoblastoma ProteinE2f Transcription FactorsApoptosisEventMutantMolecularAnimalsComplementGenetic AnalysisTissuesAnimal ModelGene ExpressionNeoplastic CellRegulationDefect

Grant awards (25)

Control of cell proliferation and differentiation by growth pathways$610,596
R35 · FY2025 · GM · contact PI
Control of cell proliferation and differentiation by growth pathways$665,330
R35 · FY2024 · GM · contact PI
Control of cell proliferation and differentiation by growth pathways$16,282
R35 · FY2024 · GM · contact PI
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway$570,160
R35 · FY2023 · GM · contact PI
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway$34,043
R35 · FY2023 · GM · contact PI
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway$570,160
R35 · FY2022 · GM · contact PI
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway$570,160
R35 · FY2021 · GM · contact PI
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway$570,160
R35 · FY2020 · GM · contact PI
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway$515,576
R35 · FY2019 · GM · contact PI
Rb and Hippo tumor suppressor pathways in differentiation$335,790
R01 · FY2018 · GM · contact PI
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway$319,800
R01 · FY2018 · GM · contact PI
Rb and Hippo tumor suppressor pathways in differentiation$335,790
R01 · FY2017 · GM · contact PI
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway$319,800
R01 · FY2017 · GM · contact PI
Rb and Hippo tumor suppressor pathways in differentiation$335,790
R01 · FY2016 · GM · contact PI
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway$319,700
R01 · FY2016 · GM · contact PI
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway$319,600
R01 · FY2015 · GM · contact PI
Genetic integration of pRB and Hippo tumor suppressor pathways$296,528
R01 · FY2014 · GM · contact PI
Genetic integration of pRB and Hippo tumor suppressor pathways$286,150
R01 · FY2013 · GM · contact PI
Genetic integration of pRB and Hippo tumor suppressor pathways$296,528
R01 · FY2012 · GM · contact PI
Genetic integration of pRB and Hippo tumor suppressor pathways$284,554
R01 · FY2011 · GM · contact PI
Characterization of novel modifiers of dE2F/RBF function$258,256
R01 · FY2011 · GM · contact PI
Characterization of novel modifiers of dE2F/RBF function$260,865
R01 · FY2010 · GM · contact PI
Characterization of novel modifiers of dE2F/RBF function$263,500
R01 · FY2009 · GM · contact PI
Characterization of novel modifiers of dE2F/RBF function$263,500
R01 · FY2008 · GM · contact PI
Characterization of novel modifiers of dE2F/RBF function$263,500
R01 · FY2007 · GM · contact PI